上海生物药品周以全球创新为焦点, 推出新的医疗群组及国家基金, Shanghai's Biopharma Week launched with global innovation focus, new medical clusters, and a state fund.

2025年上海国际生物制药工业周于10月13日开始,重点是全球合作和创新,包括论坛、展览和投资会议,持续至10月17日。 International Biopharma Industry Week Shanghai 2025 began on October 13 with a focus on global collaboration and innovation, featuring forums, exhibitions, and investment sessions through October 17. 这次活动由上海政府和工业伙伴举办,旨在加强该市作为全球生物药品中心的作用。 The event, organized by Shanghai’s government and industry partners, aims to strengthen the city’s role as a global biopharma hub. 主要公告包括:在浦东、明汉和贾丁启动三个高端医疗设备集群,推出一个新的生物制药技术标准研究基地,以及成立国有资本投资基金。 Key announcements include the launch of three high-end medical device clusters in Pudong, Minhang, and Jiading, the unveiling of a new biopharma technical standards research base, and the formation of a state-owned capital investment fund. 包括科学家、监管者和工业领导人在内的800多名与会者出席了会议,来自中国国家海洋环境保护局和科学技术部的全球专家和官员分享了他们的见解。 Over 800 participants, including scientists, regulators, and industry leaders, attended, with insights shared by global experts and officials from China’s NMPA and Ministry of Science and Technology.